BIVALIRUDIN

Course overview

BIVALIRUDIN IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE MYOCARDIAL INFARCTION. IT IS IN THE DIRECT THROMBIN INHIBITOR CLASS OF DRUGS. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR BIVALIRUDIN AS A VALUABLE AGENT IN THE THERAPY ACUTE MYOCARDIAL INFARCTION, IN ADDITION TO ITS BROADER APPLICATIONS IN THROMBOEMBOLIC DISEASE, CARDIOPULMONARY BYPASS, AND EXTRACORPOREAL MEMBRANE OXYGENATION. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE HEALTHCARE TEAM IN THE MANAGEMENT OF THE PATIENTS AS PREVIOUSLY MENTIONED.